Philip Gutin
Chairman · New York Presbyterian Hospital
Credentials: · ·
History
Research
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Nature Genetics · 2019 · 3,156 citations
Cell · 2020 · 852 citations
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO
Science · 2013 · 742 citations
- DL
38 papers
- WW
37 papers
- PS
35 papers
- TP
35 papers
31 papers · 2 as a fellow
28 papers
- VT
24 papers · 2 as a resident
- CB
22 papers · 1 as a resident
Clinical trials
- 2005–2017
Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
- 2000–2009
Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
- 2009–2017
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Study director · Completed · Phase 3
NovoCure Ltd.